Leerink Partners

Leerink Partners

$98,000,000 Venture capital (Series C)
FinSMEs

Kinnate Biopharma Closes $98M Series C Financing

$30,000,000 Venture capital
FinSMEs , Pulse 2.0

Kyruus Raises $30M in Funding

Pulse 2.0

Gilead Sciences (GILD) Signs $2 Billion Deal With Arcus Biosciences (RCUS)

Xconomy

Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq

Xconomy

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

FinSMEs

Generation Bio Raises $110M in Series C Financing

$74,500,000 Venture capital (Series B)
Pulse 2.0 , FinSMEs

Precision Oncology Company Kinnate Biopharma Raises $74.5 Million

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With Arcus Biosciences Inc ...

$126,400,000 IPO
PE HUB

VC-backed BioSciences goes public

$80,000,000 Venture capital (Series B)
FinSMEs , MedCity News

Fulcrum Therapeutics Raises $80M in Series B Financing

Funding Health Science
$110,000,000 Venture capital (Series B)
FinSMEs

Precision BioSciences Raises $110M in Series B Funding

Funding
$99,700,000 IPO
PE HUB

VC-backed Avrobio rolls out IPO

Stock markets Health
$10,000,000 Venture capital
MedCity News

Health IT startup Kyruus brings in $10M to support matching patients with providers

Xconomy

Boston Tech Watch: Kyruus, Kolide, Nano-C, BookingBug

Funding
$125,000,000 Venture capital (Series B)
FinSMEs

TCR2 Therapeutics Raises $125M in Series B Financing

Funding Science
Xconomy

Arcus Bio Pulls Off IPO, Raises $120M for Cancer Immunotherapies

Health
$100,000,000 Venture capital (Series B)
FinSMEs

Generation Bio Raises $100M in Series B Financing

Funding Health Science
$60,000,000 Venture capital (Series B)
FinSMEs , Xconomy , MedCity News

Avrobio Raises $60M in Series B Financing

Health Funding
CrunchBase

Arcus Biosciences Raises $107 Million To Fight Cancer With Immunology News

Funding Health
$50,000,000 Venture capital (Series C)
Solid Biosciences

Solid Biosciences Raises Up To $50 Million In Series C Financing